Gary L. Silvey
12Patents
7h-index
10Co-inventors
59Inventor score
Filing activity: Jan 16, 2001 → Aug 16, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6943249B2 | Methods for isolating crystalline Form I of 5-azacytidine | Chemistry; Metallurgy | 35 | Expired |
| US6887855B2 | Forms of 5-azacytidine | Chemistry; Metallurgy | 32 | Expired |
| US7078518B2 | Forms of 5-Azacytidine | Chemistry; Metallurgy | 30 | Expired |
| US7772199B2 | Forms of 5-azacytidine | Chemistry; Metallurgy | 20 | Active |
| US6576647B2 | Pseudopolymorph of (—)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy -1-methyl)piperidinyl]-4H-1-benzopyran-4-one | Human Necessities | 20 | Expired |
| US7700770B2 | Methods for isolating crystalline form I of 5-azacytidine | Chemistry; Metallurgy | 18 | Expired |
| US8211862B2 | Pharmaceutical compositions comprising crystal forms of 5-azacytidine | Chemistry; Metallurgy | 14 | Active |
| US8513406B2 | Pharmaceutical compositions comprising forms of 5-azacytidine | Chemistry; Metallurgy | 2 | Active |
| US8481715B2 | Methods for isolating crystalline form I of 5-azacytidine | Chemistry; Metallurgy | 2 | Active |
| US8614313B2 | Pharmaceutical compositions comprising forms of 5-azacytidine | Chemistry; Metallurgy | 1 | Active |
| US8933097B2 | Fexofenadine suspension formulation | Human Necessities | 1 | Active |
| US8779117B2 | Pharmaceutical compositions comprising 5-azacytidine monohydrate | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.